Abstract:Objectives: Cleidocranial dysplasia (CCD) is a congenital autosomal dominant skeletal disease characterized by multiple craniofacial and dental anomalies. Here, we investigated mutation of the runt-related transcription factor 2 (RUNX2) gene, which is considered responsible for most instances of CCD in patients, in a Chinese family with CCD. Methods: Genomic DNA was extracted from the peripheral blood lymphocytes of all participants, and mutation analysis was performed using whole-exome and Sanger sequencing. Biophysical predictions of the altered protein were analyzed using various bioinformatics tools, and direct sequencing via reverse transcription polymerase chain reaction (PCR) was performed for functional analysis of the mutation. To determine the function of the mutated protein, expression of RUNX2 and integrin-binding sialoprotein (IBSP) was investigated via quantitative PCR. Results: We identified a novel splicing mutation (c.581-9 T > G) in all affected members, with this RUNX2 mutation incorporating in a new splice site to replace the canonical splice site, thereby resulting in insertion of an 8-bp fragment within the terminal exon 5 splice-acceptor site and premature translation termination. qPCR results confirmed attenuated RUNX2 expression and IBSP overexpression in the peripheral blood lymphocytes of patients. Conclusions: These results suggested that the newly identified splice-site mutation (c.581-9 T > G) in RUNX2 was responsible for CCD in this family through its alteration of RUNX2 activity and upregulated IBSP levels. These findings extend the mutational spectrum of the RUNX2 gene and might contribute to genetic diagnosis and counseling of families with CCD.

Identification of a novel RUNX2 gene mutation and early diagnosis of CCD in a cleidocranial dysplasia suspected Iranian family

Mutation Analysis of the RUNX2 Gene in a Family with Cleidocranial Dysplasia

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

[Cleidocranial Dysplasia: Two Cases Report and Signature Analysis].

Mutations in the RUNX2 gene in a patient with Cleidocranial Dysplasia

Clinical Spectrum of Cleidocranial Dysplasia in a Family with Twins

Combined Orthodontic-Surgical Sequential Treatment of Cleidocranial Dysplasia

Clinical Features and Diagnosis of Cleidocranial Dysplasia

Identification of a Novel Missense Mutation in the RUNX2 Gene in Two Patients with Cleidocranial Dysplasia from One Chinese Family

Identification of RUNX2 variants associated with cleidocranial dysplasia

Identification of a Novel Splice Site Mutation in RUNX2 Gene in a Family with Rare Autosomal Dominant Cleidocranial Dysplasia

Identification a novel de novo RUNX2 frameshift mutation associated with cleidocranial dysplasia

Identification of a Novel Mutation in the Runt-Related Transcription Factor 2 Gene in a Chinese Family With Cleidocranial Dysplasia

Identification of a familial cleidocranial dysplasia with a novel RUNX2 mutation and establishment of patient-derived induced pluripotent stem cells

A novel single-base deletion of the RUNX Family Transcription Factor 2 gene associated with cleidocranial dysplasia

Molecular Genetics of Cleidocranial Dysplasia

Whole-exome sequencing identification of a novel splicing mutation of RUNX2 in a Chinese family with cleidocranial dysplasia

Cleidocranial dysplasia: Clinical, endocrinologic and molecular findings in 15 patients from 11 families

Analysis of Novel RUNX2 Mutations in Chinese Patients with Cleidocranial Dysplasia